Ozempic shortages in the EU will not affect all Member States
An intermittent shortage of the diabetes drug Ozempic in the European Union, which is expected to persist into the last quarter of 2024 due to high demand, will not affect all member states, Danish pharmaceutical company Novo Nordisk said.
BELIEBTE BEITRÄGE
Thousands under evacuation orders in California due to wildfires
November 8, 2024
EU scientists say 2024 will be the hottest year on record
November 8, 2024
LIVEÜBERTRAGUNG